Faculty Information
日本語 >>
TOP page
>
Medical Education Center
>
Medical Education Center
Journal
Presentation
(Last updated : 2024-05-08 11:51:01)
Natsuaki Masaru
Department
Hyogo Medical University(Specialty Division) Dermatology, Clinical Medicine Seminars
Position
■
Journal
1.
Original article
Optimal patch application time in the evaluation of skin irritation 2013/05
2.
Introduction
Kampo treatment for allergic skin diseases 2014/08
3.
Case report
Case of tick-associated rash illness caused by Amblyomma testudinarium 2014/09
4.
Original article
Assessment of fever for infection control using thermography - facial thermography in patients with influenza - 2015/01
5.
Case report
Allergic contact dermatitis due to ripasudil hydrochloride hydrate in eye-drops: A case report 2018/02
6.
Case report
Two cases of Japanese spotted fever infected in Rokko mountain near urban area of southern Hyogo Prefecture 2018/06
7.
Case report
Anaphylaxis caused by a centipede bite: A "true" type-I allergic reaction 2018/07
8.
Case report
A case of photoallergic dermatitis caused by pirfenidone 2018/10
9.
Original article
Epidemiological survey of tick bites occurring in Hyogo Prefecture from 2014
through 2018 2020/03
10.
Original article
Real-world use of dupilumab for 53 patients with atopic dermatitis in Japan 2020/04
11.
Original article
Effectiveness and safety of tacrolimus ointment combined with dupilumab for patients with atopic dermatitis in real-world clinical practice. 2021/10
12.
Original article
Dupilumab in atopic dermatitis patients with chronic hepatitis B 2022/04
13.
Original article
Evaluation of long-term disease control with dupilumab therapy using the Atopic Dermatitis Control Tool in real-world clinical practice 2022/04
14.
Original article
Single-cell RNA sequencing of mycosis fungoides reveals a cluster of actively proliferating lymphocytes 2022/05
15.
Original article
Atopic dermatitis patients may maintain long-term remission after discontinuation of dupilumab 2022/06
16.
Case report
A pediatric case of exudative erythema multiforme probably associated with asymptomatic COVID-19. 2023/08
17.
Original article
Real-world efficacy of dupilumab re-administration after discontinuation in patients with atopic dermatitis. 2024/01
Display 5 items
Display all(17)
■
Presentation
1.
Tick-associated rash illness (Oral presentation,Symposium/Workshop/Panel Discussion) 2014/07/17
2.
Dupilumab’s Effects on Circulating Group 2 Innate Lymphoid Cell and T Helper Type 2 Cell Populations in Patients with Atopic Dermatitis (Web announcement,General Lecture) 2020/12/13